CIK 0001714899 · Large accelerated filer
Denali Therapeutics Inc.
Sign in to watch- Ticker
- DNLI
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 463872213
- Phone
- (650) 866-8547
- Business address
- 161 OYSTER POINT BLVD., SOUTH SAN FRANCISCO, CA, 94080
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $363,678
- in 3 filings, $327K under 10b5-1 plans
Net −$363,678. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2017-12-12 | FIL Ltd See Remark 1 | Conversion | +1,065,616 | 1,383,774 | ||
| 2017-12-12 | FIL Ltd See Remark 1 | Conversion | +21,942 | 1,405,716 | ||
| 2017-12-12 | FIL Ltd See Remark 1 | Conversion | +54,854 | 1,460,570 | ||
| 2017-12-12 | FIL Ltd See Remark 1 | Conversion | +293,204 | 380,597 | ||
| 2017-12-12 | FIL Ltd See Remark 1 | Conversion | +6,027 | 386,624 | ||
| 2017-12-12 | FIL Ltd See Remark 1 | Conversion | +15,068 | 401,692 | ||
| 2017-12-12 | FIL Ltd See Remark 1 | Conversion | +292,303 | 379,427 | ||
| 2017-12-12 | FIL Ltd See Remark 1 | Conversion | +6,008 | 385,435 | ||
| 2017-12-12 | FIL Ltd See Remark 1 | Conversion | +15,021 | 400,456 | ||
| 2017-12-12 | FIL Ltd See Remark 1 | Conversion | +3,755 | 4,876 | ||
| 2017-12-12 | FIL Ltd See Remark 1 | Conversion | +77 | 4,953 | ||
| 2017-12-12 | FIL Ltd See Remark 1 | Conversion | +193 | 5,146 | ||
| 2017-12-12 | FIL Ltd See Remark 1 | Conversion | +662 | 859 | ||
| 2017-12-12 | FIL Ltd See Remark 1 | Conversion | +13 | 872 | ||
| 2017-12-12 | FIL Ltd See Remark 1 | Conversion | +34 | 906 | ||
| 2017-12-12 | FIL Ltd See Remark 1 | Conversion | +1,008 | 1,308 | ||
| 2017-12-12 | FIL Ltd See Remark 1 | Conversion | +20 | 1,328 | ||
| 2017-12-12 | FIL Ltd See Remark 1 | Conversion | +51 | 1,379 | ||
| 2017-12-12 | FIL Ltd See Remark 1 | Conversion · Series A-1 Convertible Preferred Stock | −1,397,326 | 0 | ||
| 2017-12-12 | FIL Ltd See Remark 1 | Conversion · Series A-1 Convertible Preferred Stock | −1,065,616 | 0 |
Page 49 of 53 · 1,053 trades